|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:abusePotential
|
yes
|
|
gptkbp:approvalYear
|
1977
|
|
gptkbp:ATCCode
|
N05BA06
|
|
gptkbp:blackBoxWarning
|
concomitant use with opioids may cause respiratory depression, coma, and death
|
|
gptkbp:CASNumber
|
846-49-1
|
|
gptkbp:chemicalFormula
|
C15H10Cl2N2O2
|
|
gptkbp:contraindication
|
acute narrow-angle glaucoma
hypersensitivity to benzodiazepines
|
|
gptkbp:controlledSubstanceSchedule
|
IV
|
|
gptkbp:drugClass
|
benzodiazepine
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:tablet
solution for injection
|
|
gptkbp:genericName
|
gptkb:lorazepam
|
|
gptkbp:halfLife
|
10-20 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ativan
|
|
gptkbp:interactsWith
|
gptkb:beer
opioids
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:overdoseTreatment
|
gptkb:flumazenil
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:riskOfDependence
|
yes
|
|
gptkbp:riskOfWithdrawal
|
yes
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
confusion
dizziness
fatigue
drowsiness
respiratory depression
weakness
|
|
gptkbp:status
|
FDA approved
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:synonym
|
gptkb:Temesta
Lorazepamum
|
|
gptkbp:usedFor
|
status epilepticus
insomnia
anxiety disorders
preoperative sedation
|
|
gptkbp:bfsParent
|
gptkb:lorazepam
gptkb:Lorazepam
|
|
gptkbp:bfsLayer
|
7
|